148 related articles for article (PubMed ID: 1697205)
1. Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
Salo JO; Rannikko S; Haapiainen R
Br J Urol; 1990 Aug; 66(2):188-92. PubMed ID: 1697205
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay of serum prostatic acid phosphatase after prostatic massage.
Pearson JC; Dombrovskis S; Dreyer J; Williams RD
Urology; 1983 Jan; 21(1):37-41. PubMed ID: 6186064
[TBL] [Abstract][Full Text] [Related]
3. Elevation of serum prostatic acid phosphatase levels after prostatic massage.
Wadström J; Huber P; Rutishauser G
Urology; 1984 Dec; 24(6):550-1. PubMed ID: 6209846
[TBL] [Abstract][Full Text] [Related]
4. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay.
Vihko P; Lukkarinen O; Kontturi M; Vihko R
Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
Canal P; Soula G
Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
[TBL] [Abstract][Full Text] [Related]
6. Rapid radioimmunoassay for prostate-specific acid phosphatase in human serum.
Vihko P; Kostama A; Jänne O; Sajanti E; Vihko R
Clin Chem; 1980 Oct; 26(11):1544-7. PubMed ID: 6158382
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of serum prostatic acid phosphatase assay based on the immunoenzymatic method (TZR-516)].
Ikemoto I; Machida T; Oishi Y; Onishi T; Shirai T; Imanaka K
Hinyokika Kiyo; 1989 Sep; 35(9):1639-42. PubMed ID: 2479240
[TBL] [Abstract][Full Text] [Related]
8. Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
el-Shirbiny AM; Shridhar P; al Adnani MS; Suresh LK
Urology; 1988 Nov; 32(5):469-73. PubMed ID: 2460989
[TBL] [Abstract][Full Text] [Related]
9. [Experience with prostate-specific antigen in patients with prostatic cancer].
Romics I; Bach D
Orv Hetil; 1989 Dec; 130(52):2797-800. PubMed ID: 2481833
[TBL] [Abstract][Full Text] [Related]
10. Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer.
Huber PR; Zaugg T; Linder E; Hagmaier V; Rutishauser G
Urol Res; 1982; 10(2):75-80. PubMed ID: 6180539
[TBL] [Abstract][Full Text] [Related]
11. Secretion into and elimination from blood circulation of prostate specific acid phosphatase, measured by radioimmunoassay.
Vihko P; Schroeder FH; Lukkarinen O; Vihko R
J Urol; 1982 Jul; 128(1):202-4. PubMed ID: 6180187
[TBL] [Abstract][Full Text] [Related]
12. Circadian and day-to-day variation of prostatic acid phosphatase.
Nissenkorn I; Mickey DD; Miller DB; Soloway MS
J Urol; 1982 Jun; 127(6):1122-4. PubMed ID: 6177878
[TBL] [Abstract][Full Text] [Related]
13. The value of acid phosphatase measurements in predicting extraprostatic cancer growth before radical prostatectomy.
Salo JO; Rannikko S
Br J Urol; 1988 Nov; 62(5):439-42. PubMed ID: 3208023
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical measurement of serum prostatic acid phosphatase (PAP). Clinical evaluation of radioimmunoassay and counter immunoelectrophoresis.
Gupta MK; Rajaraman S; Gupta SK; Hewitt CB; Deodhar SD
Am J Clin Pathol; 1981 Oct; 76(4):430-6. PubMed ID: 6170220
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum arginase activity in benign prostatic hypertrophy and prostatic cancer.
Elgün S; Keskineğe A; Yilmaz E; Baltaci S; Bedük Y
Int Urol Nephrol; 1999; 31(1):95-9. PubMed ID: 10408309
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
[TBL] [Abstract][Full Text] [Related]
17. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
[TBL] [Abstract][Full Text] [Related]
18. Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
Bauer HW; Schmeller NT
Urology; 1984 Mar; 23(3):247-51. PubMed ID: 6199879
[TBL] [Abstract][Full Text] [Related]
19. Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase.
Foti AG; Cooper JF; Herschman H; Malvaez RR
N Engl J Med; 1977 Dec; 297(25):1357-61. PubMed ID: 73133
[TBL] [Abstract][Full Text] [Related]
20. Human prostatic acid phosphatases: III. Counterimmunoelectrophoresis for rapid identification.
McDonald I; Rose NR; Pontes EJ; Choe BK
Arch Androl; 1978 May; 1(3):235-9. PubMed ID: 83816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
